|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.23 CNY | -2.02% |
|
+1.23% | -23.16% |
Shanghai Hile Bio-Technology Co., Ltd. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was CNY 299.99 million compared to CNY 347.29 million a year ago. Net income was CNY 121.61 million compared to CNY 53.86 million a year ago.
Basic earnings per share from continuing operations was CNY 0.19 compared to CNY 0.08 a year ago. Diluted earnings per share from continuing operations was CNY 0.19 compared to CNY 0.08 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -23.16% | 748M | |
| -15.35% | 76.34B | |
| -9.19% | 6.67B | |
| +24.75% | 3.7B | |
| -1.11% | 3.21B | |
| +6.08% | 1.52B | |
| -15.13% | 1.37B | |
| -25.63% | 1.24B | |
| -7.62% | 1.21B | |
| -10.84% | 1.17B |
SHANGHAI HILE BIO-TECHNOLOGY CO., LTD. 
